Ultragenyx Pharmaceutical | Driftsresultat



Operating Profit Lave om Dato
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Insmed USD -230414000 16.98M 2024-12
Ionis Pharmaceuticals USD -110823000 37.83M 2024-12
Kyowa Hakko Kirin JPY 26.93B 2.53B 2024-09
MacroGenics USD 54.19M 112.37M 2024-09
Moderna USD -1246000000 1.18B 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
PTC Therapeutics USD -62489000 7.98M 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Ultragenyx Pharmaceutical Driftsresultat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.